Latest Cost Management News

BlueScope Steel reported a robust first half of FY2026 with underlying EBIT soaring 81% to $557.5 million and announced a $3.00 per share shareholder return plan, while decisively rejecting a $30 per share takeover proposal.

AVITA Medical closed 2025 with steady revenue growth and over 80% gross margin, setting the stage for a confident revenue forecast of up to US$85 million in 2026. The company also secured a new debt facility with improved terms, underpinning its growth ambitions.

AVITA Medical reported steady Q4 losses amid reimbursement challenges but achieved 11% revenue growth for 2025 and secured a $60 million credit facility to fuel future expansion.

Alkane Resources has reported record-breaking financial and operational results for the first half of FY2026, driven by strong gold and antimony production across its expanded three-mine portfolio. The company’s robust cash flow and profit position set a confident tone for meeting full-year guidance.

Microequities Asset Management Group Limited has reported a robust half-year performance with a 41% jump in profit after tax and record funds under management reaching $657 million. The company also announced a 21% increase in its fully franked interim dividend.

Dusk Group Limited has reported a solid 5.2% increase in net profit for the half year ended December 2025, alongside a 5.1% rise in revenue. The company also announced a fully franked interim dividend doubling the prior payout, signalling confidence in its retail operations.

Coast Entertainment has reported a robust half-year performance, with ticket sales and visitation hitting new highs and EBITDA significantly exceeding prior periods. The launch of King Claw and a new Olympic partnership are key drivers of momentum.

Nick Scali Limited posted a robust half-year result with revenue up 7.2% and net profit soaring 36.4%, driven by strong ANZ growth despite ongoing UK losses. The company also declared a fully franked interim dividend of 39 cents per share.

GQG Partners reported a 7.1% increase in funds under management for 2025, driven by strong investment performance despite net outflows, while declaring a solid fourth-quarter dividend.

OncoSil Medical’s CEO Nigel Lange has agreed to a 10% salary reduction, opting instead to receive shares at a significant premium, reinforcing executive commitment to shareholder value and cost discipline.

AMP Limited reported a robust FY25 with underlying NPAT up 20.8%, driven by strong cashflow growth, cost reductions, and new product launches including AMP Bank GO and AMP Lifetime Pension. The company sets a steady course for FY26 with continued focus on retirement solutions and AI-driven innovation.

South32 Limited reported a 29% rise in profit for the half year ended December 2025, driven by higher base and precious metals prices and solid operational performance. The company declared a fully-franked interim dividend and maintained its FY26 production guidance, while advancing key projects and managing portfolio transitions.